Concepedia

Yanliang Kang

YK

3

Publications

47

Citations

3

H-Index

2019

Active since

Affiliations

State Key Laboratory of Natural Medicine(Current)

China Pharmaceutical University

Yanliang Kang is an author at State Key Laboratory of Natural Medicine specializing in engineering, tumor immunity, and nanobiotechnology.

Top concepts

MedicineImmunologyEngineeringCell BiologyNanomedicineImmunotherapyNanoparticlesTumor ImmunityImmuno-oncologyCross-protection

Publications per year

2019–2023

3

Publications

3

PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responses

Hong Tian, Yanliang Kang, Xiaodao Song et al. · Cancer Letters · 2020 · 24 citations

Tumor Immunology, Cancer Immunosurveillance, Pd1/pdl1 Pathway +10

Self-assembled nanoparticles based on DNA origami and a nitrated T helper cell epitope as a platform for the development of personalized cancer vaccines

Yanliang Kang, Wanli Zhang, Qiumin Yu et al. · Cancer Immunology Immunotherapy · 2023 · 12 citations · Full text

Nanoparticles, Nanomedicine, Cross-protection +9

Efficient Acquisition of Fully Human Antibody Genes against Self-Proteins by Sorting Single B Cells Stimulated with Vaccines Based on Nitrated T Helper Cell Epitopes

Liangliang Jiang, Tao Jiang, Jianhua Luo et al. · Journal of Immunology Research · 2019 · 11 citations · Full text

Rows per page

1–3 of 3